Egalet Ltd.
🇺🇸United States
A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery
Phase 2
Completed
- Conditions
- Dental ImpactionPain
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT01356225
- Locations
- 🇺🇸
Austin Oral Surgery - PPD Development, Austin, Texas, United States
Tolerability, Safety and Pharmacokinetics of Four Formulations of Ketorolac Tromethamine in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: 30 mg Ketorolac Tromethamine with 6% Lidocaine HCl
- First Posted Date
- 2011-05-18
- Last Posted Date
- 2017-03-16
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT01355588
- Locations
- 🇬🇧
Medeval Ltd, Manchester, United Kingdom
Safety and Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain
- First Posted Date
- 2011-05-04
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 300
- Registration Number
- NCT01347853
- Locations
- 🇳🇿
Waikato Clinical Research, Hamilton, New Zealand
Single Dose Pharmacokinetics of Egalet® Hydrocodone
Phase 1
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2016-08-29
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 28
- Registration Number
- NCT00802087
Single Dose Pharmacokinetics of Egalet® Oxycodone
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2016-08-29
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT00801788
Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Moderate Drinkers
- First Posted Date
- 2008-12-04
- Last Posted Date
- 2016-09-14
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT00802308
Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine
- First Posted Date
- 2007-06-07
- Last Posted Date
- 2016-09-30
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 173
- Registration Number
- NCT00483717
- Locations
- 🇩🇪
Volker Pfaffenrath, Munich, Bavaria, Germany
A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients
- First Posted Date
- 2007-03-12
- Last Posted Date
- 2016-08-29
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT00446069
- Locations
- 🇱🇹
Site 51, Kaunas, Lithuania
🇵🇱Site 62, Poznań, Poland
🇵🇱Site 64, Wrocław, Poland
A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2016-08-29
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 14
- Registration Number
- NCT00444834
- Locations
- 🇩🇰
Site 02, Esbjerg, Denmark
🇩🇰Site 01, Frederiksberg, Denmark
Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery
Phase 3
Completed
- Conditions
- Postoperative Pain
- Interventions
- Drug: Intranasal Placebo
- First Posted Date
- 2005-12-19
- Last Posted Date
- 2017-02-08
- Lead Sponsor
- Egalet Ltd
- Target Recruit Count
- 321
- Registration Number
- NCT00266786
- Locations
- 🇺🇸
Methodist Hospital, Arcadia, California, United States
🇺🇸Glendale Adventist Medical Center, Glendale, California, United States
🇳🇿Waikato Clinical Research, Hamilton, New Zealand
© Copyright 2025. All Rights Reserved by MedPath